By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


rEVO Biologics 

175 Crossing Boulevard

Framingham  Massachusetts  01702  U.S.A.
Phone: 508-620-9700 Fax: 508-370-3797



Company News
CRISPR Appoints Former rEVO Biologics Exec as CFO 3/10/2016 5:54:32 AM
rEVO Biologics Release: Study Reports Significant Increase In Incidence Of Preeclampsia, A Potentially Life-Threatening Pregnancy Complication 10/23/2015 10:31:45 AM
rEVO Biologics Supports National Preeclampsia Awareness Month 5/14/2015 11:13:01 AM
rEVO Biologics Provides Grant To Yale University To Establish A Center Of Advancement For Preeclampsia 2/3/2015 11:12:26 AM
rEVO Biologics Announces Enrollment Of First Patient In Phase 3 Trial Of Atryn® To Treat Early Onset Preeclampsia (PRESERVE-1) 7/24/2014 11:48:03 AM
Former Genzyme Corporation (GENZ) Subsidiary rEVO Biologics Files For $75 Million IPO 6/30/2014 7:11:44 AM
rEVO Biologics Initiates PRESERVE-1 Phase 3 Clinical Trial For ATryn® In Early-Onset Preeclampsia 3/31/2014 8:06:29 AM
rEVO Biologics Announces The Submission Of An IND For Atryn® In Preeclampsia 2/25/2014 8:58:06 AM